Cleared Traditional

K822759 - ABBOTT LABORATORIES PROLACTIN EIA

K822759 is an FDA 510(k) clearance for ABBOTT LABORATORIES PROLACTIN EIA, manufactured by Abbott Laboratories. The device is a Class 1 Chemistry device with product code CFT cleared through the Traditional 510(k) pathway after a 37-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1982
Decision
37d
Days
Class 1
Risk

K822759 is an FDA 510(k) clearance for the ABBOTT LABORATORIES PROLACTIN EIA. Classified as Radioimmunoassay, Prolactin (lactogen) (product code CFT), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on October 21, 1982 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1625 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K822759

510(k) Number K822759 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 1982
Decision Date October 21, 1982
Days to Decision 37 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 88d · This submission: 37d
Pathway characteristics
Predicate-based equivalence.

CFT Device Classification - Class 1, General Controls

Product Code CFT Radioimmunoassay, Prolactin (lactogen)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1625
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CFT Radioimmunoassay, Prolactin (lactogen)

All 56
Devices cleared under the same product code (CFT) and FDA review panel - the closest regulatory comparables to K822759.
TANDEM - EPRL
K843804 · Hybritech, Inc. · Nov 1984
PROLACTIN RIABEAD PROLACTIN RADIOIMM
K841118 · Abbott Laboratories · May 1984
COAT-A-COUNT NHS-PROLACTIN KIT AND
K833925 · Diagnostic Products Corp. · Jan 1984
TANDEM PROLACTIN KIT
K821545 · Hybritech, Inc. · Jun 1982
PROLACTIN (125-I) RADIOIMMUNOASSAY KIT
K821305 · Bd Becton Dickinson Vacutainer Systems Preanalytic · May 1982
CENTRIA PROLACTIN TEST SET
K813572 · Ventrex Laboratories, Inc. · Mar 1982